Search for: "Teva Pharmaceuticals"
Results 361 - 380
of 1,423
Sort by Relevance
|
Sort by Date
23 Jul 2018, 2:38 pm
Mylan Pharmaceuticals Inc., Teva Pharmaceuticals USA, Inc., AKORN, Inc. [read post]
23 Jul 2018, 12:05 pm
Teva Pharmaceuticals USA, Inc., et al., No. 17-1229. [read post]
22 Jul 2018, 8:32 pm
IPR2016-01127, IPR2016-01128, IPR2016-01129, IPR2016-01130, IPR2016-01131, and IPR2016-01132 (and parallel IPRs filed by Petitioners Teva Pharmaceuticals USA, Inc. and Akorn, Inc., which had... [read post]
18 Jul 2018, 11:23 am
Teva Pharmaceuticals USA, Inc., a case with broad implications for the pharmaceutical industry. [read post]
13 Jul 2018, 5:48 pm
Teva Parenteral Meds. [read post]
5 Jul 2018, 8:00 am
” On a summary judgment motion by Teva, the U.S. [read post]
5 Jul 2018, 8:00 am
” On a summary judgment motion by Teva, the U.S. [read post]
5 Jul 2018, 7:20 am
Teva Pharmaceuticals, USA, Inc., 429 F.3d 1364 (Fed. [read post]
5 Jul 2018, 7:20 am
Teva Pharmaceuticals, USA, Inc., 429 F.3d 1364 (Fed. [read post]
29 Jun 2018, 11:13 am
Already on October 16, 2017, Novartis discovered that Teva was commercializing generic versions of the said pharmaceutical in France. [read post]
26 Jun 2018, 8:51 pm
Teva Pharmaceuticals USA Inc., Docket No. 17-1229.... [read post]
26 Jun 2018, 8:17 am
Teva Pharmaceuticals USA, Inc. [read post]
26 Jun 2018, 8:17 am
Teva Pharmaceuticals USA, Inc. [read post]
25 Jun 2018, 10:00 pm
In a lawsuit with Teva Pharmaceuticals USA, the Federal Circuit said it was a bar because the existence of the sale was made public. [read post]
25 Jun 2018, 11:38 am
Teva Pharmaceuticals [docket; cert. petition, PDF] is whether, under the Leahy-Smith America Invents Act, an inventor’s sale of an invention to a third party that is obligated to keep the invention confidential qualifies as “prior art” for purposes of determining the patentability of the invention. [read post]
25 Jun 2018, 7:51 am
Teva Pharmaceuticals USA: Whether, under federal patent law, an inventor’s sale of an invention to someone who is required to keep the invention confidential constitutes “prior art” for purposes of determining whether the invention is patentable. [read post]
25 Jun 2018, 7:03 am
Teva Pharmaceuticals USA Inc., Docket No. 17-1229. [read post]
21 Jun 2018, 4:00 pm
Teva Pharmaceuticals USA Inc. 17-1229 Issue: Whether, under the Leahy-Smith America Invents Act, an inventor’s sale of an invention to a third party that is obligated to keep the invention confidential qualifies as prior art for purposes of determining the patentability of the invention. [read post]
20 Jun 2018, 5:00 pm
Teva Pharmaceuticals USA Inc., 17-1229, the bar section will be completely full on the day it is argued. [read post]
20 Jun 2018, 4:12 am
On 3 January 2017 Mepha Pharma AG, a Swiss subsidiary of Teva, filed a revocation action against Gilead’s Swiss SPC. [read post]
